No Red Tape For Addiction Treatment Act
Do you support it?
Want to know if it passes?
We'll email you when S 3522 moves — a committee vote, a floor vote, or a signature. Nothing else.
Free forever · unsubscribe in one click.
Your answer was recorded either way.
Which district are you in?
Your ZIP is all we need to match you to your own representatives — so we can tell you how they voted on S 3522.
You're tracking S 3522
We'll email you the moment it moves.
S 3522 — No Red Tape For Addiction Treatment Act
Last action — Read twice and referred to the Committee on Finance.
No card. One bill, free forever — alerts when it moves.
-
✓Introduced
-
2In Committee
-
3Passed Senate
-
4Passed House
-
5To Executive
-
6Enacted
This bill is in committee in the Senate. Introduced December 17, 2025. It must pass committee before a floor vote.
Next likely step: a committee vote, then a floor vote in the Senate.
Prognosis
Where this bill stands today.
Odds of enactment
LowHow often bills like it became law.
-
In Committee
Current position in the legislative process.
-
2 sponsors
1 primary, 1 co-sponsors signed on.
-
Bipartisan support
Sponsored across 2 parties (1 D · 1 R) — cross-party backing.
Prognosis reads this bill's own signals — stage, sponsorship breadth, committee status, recorded votes and cross-state momentum. Odds come from a model trained on which bills have become law.
Bill Text
- Introduced Introduced in Senate Current html December 17, 2025
Sections of law this bill changes
2 sections in 1 lawFrom the bill's own amending language, matched to the official United States Code (current through Public Law 119-121).
Social security · 42 U.S.C. ch. 7 2 sections
-
§ 1396d Definitions Amends
42 U.S.C. § 1396d
The law today
For purposes of this subchapter— (a) Medical assistance The term “medical assistance” means payment of part or all of the cost of the following care and services or the care and services themselves, or both (if provided in or after the third month before the month in which the recipient makes application for assistance or, in the case of medicare cost-sharing with respect to a qualified medicare beneficiary described in subsection (p)(1), if provided after the month in which the individual becomes such a beneficiary) for individuals, and, with respect to physicians’ or dentists’ services, at the option of the State, to individuals (other than individuals with respect to whom there is being paid, or who are eligible, or would be eligible if they were not in a medical institution, to have paid with respect to them a State supplementary payment and are eligible for medical assistance equal in amount, duration, and scope to the medical assistance made available to individuals described in section 1396a(a)(10)(A) of this title) not receiving aid or assistance under any plan of the State approved under subchapter I, X, XIV, or XVI, or part A of subchapter IV, and with respect to whom supplemental security income benefits are not being paid under subchapter XVI, who are— (i) under the age of 21, or, at the option of the State, under the age of 20, 19, or 18 as the State may choose, (ii) relatives specified in section 606(b)(1) 1 of this title with whom a child is living if such child is (or would, if needy, be) a dependent child under part A of subchapter IV, (iii) 65 years of age or older, (iv) blind, with respect to States eligible to participate in the State plan program established under subchapter XVI, (v) 18 years of age or older and permanently and totally disabled, with respect to States eligible to participate in the State plan program established under subchapter XVI, (vi) persons essential (as described in the second sentence of this subsection) to individuals receiving aid or assistance under State plans approved under subchapter I, X, XIV, or XVI, (vii) blind or disabled as defined in section 1382c of this title, with respect to States not eligible to participate in the State plan program established under subchapter XVI, (viii) pregnant women, (ix) individuals provided extended benefits under section 1396r–6 of this title, (x) individuals described in section 1396a(u)(1) of this title, (xi) individuals described in section 1396a(z)(1) of this title, (xii) employed individuals with a medically improved disability (as defined in subsection (v)), (xiii) individuals described in section 1396a(aa) of this title, (xiv) individuals described in section 1396a(a)(10)(A)(i)(VIII) or 1396a(a)(10)(A)(i)(IX) of this title, (xv) individuals described in section 1396a(a)(10)(A)(ii)(XX) of this title, (xvi) individuals described in section 1396a(ii) of this title, (xvii) individuals who are eligible for home and community-based services under needs-based criteria established under paragraph (1)(A) of section 1396n(i) of this title, or who are eligible for home and community-based services under paragraph (6) of such section, and who will receive home and community-based services pursuant to a State plan amendment under such subsection, or (xviii) individuals who, but for earnings in excess of the limit established under subsection (q)(2)(B), would be considered to be receiving supplemental security income, and who are at least 16 years of age, but whose income and resources are insufficient to meet all of such cost— (1) inpatient hospital services (other than services in an institution for mental diseases); (2) (A) outpatient hospital services, (B) consistent with State law permitting such services, rural health clinic services (as defined in subsection (l)(1)) and any other ambulatory services which are offered by a rural health clinic (as defined in subsection (l)(1)) and which are otherwise included in the plan, and (C) Federally...434 other bills also change this section · Follow it → Official text at uscode.house.gov ↗
-
§ 1396r-8 Payment for covered outpatient drugs Amends
42 U.S.C. § 1396r-8 — at 1396r-8(d)(1)(A)
The law today
(a) Requirement for rebate agreement (1) In general In order for payment to be available under section 1396b(a) of this title or under part B of subchapter XVIII for covered outpatient drugs of a manufacturer, the manufacturer must have entered into and have in effect a rebate agreement described in subsection (b) with the Secretary, on behalf of States (except that, the Secretary may authorize a State to enter directly into agreements with a manufacturer), and must meet the requirements of paragraph (5) (with respect to drugs purchased by a covered entity on or after the first day of the first month that begins after November 4, 1992) and paragraph (6). Any agreement between a State and a manufacturer prior to April 1, 1991, shall be deemed to have been entered into on January 1, 1991, and payment to such manufacturer shall be retroactively calculated as if the agreement between the manufacturer and the State had been entered into on January 1, 1991. If a manufacturer has not entered into such an agreement before March 1, 1991, such an agreement, subsequently entered into, shall become effective as of the date on which the agreement is entered into or, at State option, on any date thereafter on or before the first day of the calendar quarter that begins more than 60 days after the date the agreement is entered into. (2) Effective date Paragraph (1) shall first apply to drugs dispensed under this subchapter on or after January 1, 1991. (3) Authorizing payment for drugs not covered under rebate agreements Paragraph (1), and section 1396b(i)(10)(A) of this title, shall not apply to the dispensing of a single source drug or innovator multiple source drug if (A)(i) the State has made a determination that the availability of the drug is essential to the health of beneficiaries under the State plan for medical assistance; (ii) such drug has been given a rating of 1–A by the Food and Drug Administration; and (iii)(I) the physician has obtained approval for use of the drug in advance of its dispensing in accordance with a prior authorization program described in subsection (d), or (II) the Secretary has reviewed and approved the State’s determination under subparagraph (A); or (B) the Secretary determines that in the first calendar quarter of 1991, there were extenuating circumstances. The preceding sentence shall not apply to a single source drug or innovator multiple source drug of a manufacturer for any period described in section 5000D(c)(1) of the Internal Revenue Code of 1986 with respect to the manufacturer. (4) Effect on existing agreements In the case of a rebate agreement in effect between a State and a manufacturer on November 5, 1990, such agreement, for the initial agreement period specified therein, shall be considered to be a rebate agreement in compliance with this section with respect to that State, if the State agrees to report to the Secretary any rebates paid pursuant to the agreement and such agreement provides for a minimum aggregate rebate of 10 percent of the State’s total expenditures under the State plan for coverage of the manufacturer’s drugs under this subchapter. If, after the initial agreement period, the State establishes to the satisfaction of the Secretary that an agreement in effect on November 5, 1990, provides for rebates that are at least as large as the rebates otherwise required under this section, and the State agrees to report any rebates under the agreement to the Secretary, the agreement shall be considered to be a rebate agreement in compliance with the section for the renewal periods of such agreement. (5) Limitation on prices of drugs purchased by covered entities (A) Agreement with Secretary A manufacturer meets the requirements of this paragraph if the manufacturer has entered into an agreement with the Secretary that meets the requirements of section 256b of this title with respect to covered outpatient drugs purchased by a covered entity on or after the first day of the first month...124 other bills also change this section · Follow it → Official text at uscode.house.gov ↗
Also cites: 42 U.S.C. § 1301
Compared against current U.S. Code AI-generated reading aid — verify against the official bill.
The bill requires state Medicaid programs to provide at least one formulation of each type of medication for treating opioid use disorder without prior authorization or dosage limitations.
-
42 U.S.C. 1396d
(2) and (3)→ (2), (3), and (4)This change adds an additional category to the existing definitions of medical assistance.
-
42 U.S.C. 1396d
``(4) Provision of medication-assisted treatment without prior authorization.--``(A) In general.--A State plan (or a waiver of such plan) shall provide coverage of at least 1 formulation of each drug and biological product described in paragraph (1)(A) (which shall include, if available with respect to such a drug or biological product, a formulation that is long-lasting and injectable) that is not subject to prior authorization or limitations on dosage as a condition of coverage or payment for such drug or biological product.``(B) Rule of construction.--The requirement under subparagraph (A) to provide coverage of at least 1 formulation of each drug and biological product described in paragraph (1)(A) shall not be construed as modifying or limiting the ability of a State to establish a formulary that is consistent with the requirements of section 1927(d)(4).''
This new provision mandates that states must cover at least one formulation of opioid use disorder medications without prior authorization or dosage limits.
-
42 U.S.C. 1396r-8(d)(1)(A)
A State→ Except as provided in section 1905(ee)(4), a StateThis change clarifies that the previously stated requirements about formularies do not apply when it comes to the new provisions on opioid medications.
Action History
-
Introduced in Senate
-
Read twice and referred to the Committee on Finance.
Sponsors
- Margaret Wood Hassan · Primary
- James C. Justice · Cosponsor
Sponsorship breakdown
Export CSV (upgrade) →1 sponsors · 1 co-sponsors · 545 not signed on
Sponsors (1)
- Hassan, Margaret Wood Democratic
Co-sponsors (1)
- Justice, James C. Republican
Not signed on (545)
545 members have not signed on to this bill.
Show all 545 →"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.
Subjects
Frequently asked questions
- Who sponsors S 3522?
- S 3522 is sponsored by Hassan, Margaret Wood (Democratic) and Justice, James C. (Republican).
- What is the current status of S 3522?
- This bill is in committee in the Senate. Introduced December 17, 2025. It must pass committee before a floor vote.
- Where can I track S 3522?
- Track S 3522 free on One Click Politics — get push/email alerts when it moves.
Make your voice heard on S 3522
Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.
Stay ahead of S 3522
Last checked for changes 4 months ago · updated continuously
One Click Politics tracks every bill in Congress and all 50 states.
Track this bill →